Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Evaluation of varicella zoster virus infection morbidity and mortality in pancreas and kidney-pancreas transplant recipients.

Netchiporouk E, Tchervenkov J, Paraskevas S, Sasseville D, Billick R.

Transplant Proc. 2013 Mar;45(2):701-4. doi: 10.1016/j.transproceed.2012.10.022. Epub 2013 Mar 1.

PMID:
23453544
2.

Disseminated varicella zoster virus infection in adult renal transplant recipients: outcome and risk factors.

Rommelaere M, Maréchal C, Yombi JC, Goffin E, Kanaan N.

Transplant Proc. 2012 Nov;44(9):2814-7. doi: 10.1016/j.transproceed.2012.09.090. Review.

PMID:
23146530
3.

Evaluation of herpes simplex virus infection morbidity and mortality in pancreas and kidney-pancreas transplant recipients.

Netchiporouk E, Tchervenkov J, Paraskevas S, Sasseville D, Billick R.

Transplant Proc. 2013 Nov;45(9):3343-7. doi: 10.1016/j.transproceed.2013.05.002.

PMID:
24182813
4.

Varicella zoster infection in renal transplant recipients: prevalence, complications and outcome.

Mustapic Z, Basic-Jukic N, Kes P, Lovcic V, Bubic-Filipi Lj, Mokos I, Kastelan Z, Zekan S.

Kidney Blood Press Res. 2011;34(6):382-6. doi: 10.1159/000328730. Epub 2011 Jun 7.

5.

Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation.

Leung TF, Chik KW, Li CK, Lai H, Shing MM, Chan PK, Lee V, Yuen PM.

Bone Marrow Transplant. 2000 Jan;25(2):167-72.

6.

Varicella infection in adult renal allograft recipients: experience at one center.

Rodriguez-Moreno A, Sanchez-Fructuoso AI, Calvo N, Ridao N, Conesa J, Marques M, Prats D, Barrientos A.

Transplant Proc. 2006 Oct;38(8):2416-8.

PMID:
17097954
7.

Prevalence and outcome of herpes zoster infection in renal transplant recipients.

Kırnap M, Akdur A, Ayvazoğlu Soy HE, Arslan H, Yıldırım S, Moray G, Haberal M.

Exp Clin Transplant. 2015 Apr;13 Suppl 1:280-3.

PMID:
25894173
8.

Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.

Wood SM, Shah SS, Steenhoff AP, Rutstein RM.

Pediatrics. 2008 Jan;121(1):e150-6. Epub 2007 Dec 17.

PMID:
18086820
9.

Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group.

Onozawa M, Hashino S, Haseyama Y, Hirayama Y, Iizuka S, Ishida T, Kaneda M, Kobayashi H, Kobayashi R, Koda K, Kurosawa M, Masauji N, Matsunaga T, Mori A, Mukai M, Nishio M, Noto S, Ota S, Sakai H, Suzuki N, Takahashi T, Tanaka J, Torimoto Y, Yoshida M, Fukuhara T.

Biol Blood Marrow Transplant. 2009 Jun;15(6):724-9. doi: 10.1016/j.bbmt.2009.03.003.

10.

Impact of the duration of antiviral prophylaxis on rates of varicella-zoster virus reactivation disease in autologous hematopoietic cell transplantation recipients.

Truong Q, Veltri L, Kanate AS, Hu Y, Craig M, Hamadani M, Cumpston A.

Ann Hematol. 2014 Apr;93(4):677-82. doi: 10.1007/s00277-013-1913-z. Epub 2013 Oct 6.

PMID:
24097085
11.

Retrospective analysis of varicella zoster virus (VZV) copy DNA numbers in plasma of immunocompetent patients with herpes zoster, of immunocompromised patients with disseminated VZV disease, and of asymptomatic solid organ transplant recipients.

Kronenberg A, Bossart W, Wuthrich RP, Cao C, Lautenschlager S, Wiegand ND, Mullhaupt B, Noll G, Mueller NJ, Speck RF.

Transpl Infect Dis. 2005 Sep-Dec;7(3-4):116-21.

PMID:
16390399
12.

Varicella-zoster virus infections in immunocompromised patients - a single centre 6-years analysis.

Wiegering V, Schick J, Beer M, Weissbrich B, Gattenlöhner S, Girschick HJ, Liese J, Schlegel PG, Eyrich M.

BMC Pediatr. 2011 May 10;11:31. doi: 10.1186/1471-2431-11-31.

13.

Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.

Breuer J, Whitley R.

Herpes. 2007 Sep;14 Suppl 2:25-9. Erratum in: Herpes. 2007 Dec;14(3):74.

PMID:
17939892
14.

Lethal varicella-zoster virus reactivation without skin lesions following renal transplantation.

Jantsch J, Schmidt B, Bardutzky J, Bogdan C, Eckardt KU, Raff U.

Nephrol Dial Transplant. 2011 Jan;26(1):365-8. doi: 10.1093/ndt/gfq542. Epub 2010 Sep 3.

PMID:
20817667
15.

Incidence and risk factors of herpes zoster among adult renal transplant recipients receiving universal antiviral prophylaxis.

Pavlopoulou ID, Poulopoulou S, Melexopoulou C, Papazaharia I, Zavos G, Boletis IN.

BMC Infect Dis. 2015 Jul 24;15:285. doi: 10.1186/s12879-015-1038-1.

16.

[Varicella and herpes zoster. Part 1: virology, epidemiology, clinical picture, laboratory diagnostics].

Wittek M, Doerr HW, Allwinn R.

Med Klin (Munich). 2010 May;105(5):334-8. doi: 10.1007/s00063-010-1061-3. Epub 2010 May 26. Review. German.

PMID:
20503007
17.

Herpes zoster guideline of the German Dermatology Society (DDG).

Gross G, Schöfer H, Wassilew S, Friese K, Timm A, Guthoff R, Pau HW, Malin JP, Wutzler P, Doerr HW.

J Clin Virol. 2003 Apr;26(3):277-89; discussion 291-3.

PMID:
12637076
18.

Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome.

Koc Y, Miller KB, Schenkein DP, Griffith J, Akhtar M, DesJardin J, Snydman DR.

Biol Blood Marrow Transplant. 2000;6(1):44-9.

19.
20.

[Analysis of varicella zoster virus infection following allogeneic stem cell transplants].

Doki N, Hoshino T, Irisawa H, Sakura T, Miyawaki S.

Rinsho Ketsueki. 2004 Oct;45(10):1090-4. Japanese.

PMID:
15553042

Supplemental Content

Support Center